Triflusal: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Triflusal == | |||
[[File:Triflusal.svg|thumb|Chemical structure of Triflusal]] | |||
Triflusal is a | '''Triflusal''' is a [[pharmaceutical drug]] that is used as an [[antiplatelet agent]]. It is primarily prescribed for the prevention of [[thromboembolic disorders]], such as [[stroke]] and [[myocardial infarction]]. Triflusal is chemically related to [[aspirin]], but it has a different mechanism of action and side effect profile. | ||
== Mechanism of Action == | |||
Triflusal works by inhibiting the enzyme [[cyclooxygenase]] (COX), which is involved in the synthesis of [[thromboxane A2]], a potent inducer of platelet aggregation. Unlike aspirin, triflusal also increases the levels of [[nitric oxide]] and [[prostacyclin]], both of which have vasodilatory and antiplatelet effects. This dual action contributes to its effectiveness in preventing blood clots. | |||
== Clinical Uses == | == Clinical Uses == | ||
Triflusal is used in the prevention of thromboembolic events in patients with a history of [[transient ischemic attack]]s (TIAs) or [[ischemic stroke]]. It is also used in patients with [[peripheral artery disease]] and those who have undergone [[coronary artery bypass grafting]] (CABG). The drug is often chosen for patients who are intolerant to aspirin or who have a higher risk of bleeding. | |||
Triflusal is | |||
== Side Effects == | == Side Effects == | ||
Common side effects of triflusal include [[gastrointestinal]] disturbances such as [[nausea]], [[vomiting]], and [[diarrhea]]. Unlike aspirin, triflusal has a lower risk of causing [[gastrointestinal bleeding]]. Other side effects may include [[headache]], [[dizziness]], and [[rash]]. | |||
== Pharmacokinetics == | |||
Triflusal is administered orally and is rapidly absorbed from the [[gastrointestinal tract]]. It is extensively metabolized in the liver to its active metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), which is responsible for most of its antiplatelet activity. The drug and its metabolites are excreted primarily in the urine. | |||
== | |||
Triflusal is | |||
== Related Pages == | |||
* [[Aspirin]] | |||
* [[Antiplatelet drug]] | * [[Antiplatelet drug]] | ||
* [[ | * [[Thromboembolism]] | ||
* [[Stroke]] | * [[Stroke]] | ||
== References == | |||
[[Category:Antiplatelet | {{Reflist}} | ||
[[Category:Antiplatelet drugs]] | |||
[[Category:Nonsteroidal anti-inflammatory drugs]] | [[Category:Nonsteroidal anti-inflammatory drugs]] | ||
Revision as of 11:54, 9 February 2025
Triflusal

Triflusal is a pharmaceutical drug that is used as an antiplatelet agent. It is primarily prescribed for the prevention of thromboembolic disorders, such as stroke and myocardial infarction. Triflusal is chemically related to aspirin, but it has a different mechanism of action and side effect profile.
Mechanism of Action
Triflusal works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the synthesis of thromboxane A2, a potent inducer of platelet aggregation. Unlike aspirin, triflusal also increases the levels of nitric oxide and prostacyclin, both of which have vasodilatory and antiplatelet effects. This dual action contributes to its effectiveness in preventing blood clots.
Clinical Uses
Triflusal is used in the prevention of thromboembolic events in patients with a history of transient ischemic attacks (TIAs) or ischemic stroke. It is also used in patients with peripheral artery disease and those who have undergone coronary artery bypass grafting (CABG). The drug is often chosen for patients who are intolerant to aspirin or who have a higher risk of bleeding.
Side Effects
Common side effects of triflusal include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Unlike aspirin, triflusal has a lower risk of causing gastrointestinal bleeding. Other side effects may include headache, dizziness, and rash.
Pharmacokinetics
Triflusal is administered orally and is rapidly absorbed from the gastrointestinal tract. It is extensively metabolized in the liver to its active metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), which is responsible for most of its antiplatelet activity. The drug and its metabolites are excreted primarily in the urine.
Related Pages
References
<references group="" responsive="1"></references>